|
1
|
Ungar L, Palfalvi L and Novak Z: Primary
pelvic exenteration in cervical cancer patients. Gynecol Oncol. 111
(Suppl 2):S9–S12. 2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Maggioni A, Roviglione G, Landoni F,
Zanagnolo V, Peiretti M, Colombo N, Bocciolone L, Biffi R, Minig L
and Morrow CP: Pelvic exenteration: Ten-year experience at the
European institute of oncology in Milan. Gynecol Oncol. 114:64–68.
2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Brunschwig A: Complete excision of pelvic
viscera for abdominal carcinoma; a one-stage abdominoperineal
operation with end colostomy and bilateral ureteral implantation
into the colon above the colostomy. Cancer. 1:177–183.
1948.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Berek JS, Howe C, Lagasse LD and Hacker
NF: Pelvic exenteration for recurrent gynecologic malignancy:
Survival and morbidity analysis of the 45-year experience at UCLA.
Gynecol Oncol. 99:153–159. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Forner DM and Lampe B: Intestinal
complications after pelvic exenterations in gynecologic oncology.
Int J Gynecol Cancer. 19:958–962. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Khoury-Collado F, Einstein MH, Bochner BH,
Alektiar KM, Sonoda Y, Abu-Rustum NR, Brown CL, Gardner GJ, Barakat
RR and Chi DS: Pelvic exenteration with curative intent for
recurrent uterine malignancies. Gynecol Oncol. 124:42–47.
2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Fotopoulou C, Neumann U, Kraetschell R,
Schefold JC, Weidemann H, Lichtenegger W and Sehouli J: Long-term
clinical outcome of pelvic exenteration in patients with advanced
gynecological malignancies. J Surg Oncol. 101:507–512.
2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Schmidt AM, Imesch P, Fink D and Egger H:
Indications and long-term clinical outcomes in 282 patients with
pelvic exenteration for advanced or recurrent cervical cancer.
Gynecol Oncol. 125:604–609. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Soper JT, Berchuck A, Creasman WT and
Clarke-Pearson DL: Pelvic exenteration: Factors associated with
major surgical morbidity. Gynecol Oncol. 35:93–98. 1989.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Anthopoulos AP, Manetta A, Larson JE,
Podczaski ES, Bartholomew MJ and Mortel R: Pelvic exenteration: A
morbidity and mortality analysis of a seven-year experience.
Gynecol Oncol. 35:219–223. 1989.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Eisenkop SM and Spirtos NM: Procedures
required to accomplish complete cytoreduction of ovarian cancer: Is
there a correlation with ‘biological aggressiveness’ and survival?
Gynecol Oncol. 82:435–441. 2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Marnitz S, Köhler C, Müller M, Behrens K,
Hasenbein K and Schneider A: Indications for primary and secondary
exenterations in patients with cervical cancer. Gynecol Oncol.
103:1023–1030. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ferenschild FT, Vermaas M, Verhoef C,
Ansink AC, Kirkels WJ, Eggermont AM and de Wilt JH: Total pelvic
exenteration for primary and recurrent malignancies. World J Surg.
33:1502–1508. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hawighorst-Knapstein S, Fusshoeller C,
Franz C, Trautmann K, Schmidt M, Pilch H, Schoenefuss G, Knapstein
PG, Koelbl H, Kelleher DK and Vaupel P: The impact of treatment for
genital cancer on quality of life and body image-results of a
prospective longitudinal 10-year study. Gynecol Oncol. 94:398–403.
2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Höckel M and Dornhöfer N: Pelvic
exenteration for gynaecological tumours: Achievements and
unanswered questions. Lancet Oncol. 7:837–847. 2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Căpîlna ME, Rusu SC, Laczko C, Szabo B and
Marian C: Three synchronous primary pelvic cancers-a case report.
Eur J Gynaecol Oncol. 36:216–218. 2015.PubMed/NCBI
|
|
17
|
PelvExCollaborative. Pelvic exenteration
for advanced nonrectal pelvic malignancy. Ann Surg. 270:899–905.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chiva LM, Lapuente F, González-Cortijo L,
González-Martín A, Rojo A, García JF and Carballo N: Surgical
treatment of recurrent cervical cancer: State of the art and new
achievements. Gynecol Oncol. 110 (3 Suppl 2):S60–S66.
2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Dindo D, Demartines N and Clavien PA:
Classification of surgical complications: A new proposal with
evaluation in a cohort of 6336 patients and results of a survey.
Ann Surg. 240:205–213. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bricker EM: Bladder substitution after
pelvic evisceration. Surg Clin North Am. 30:1511–1521.
1950.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Căpîlna ME, Moldovan B and Szabo B: Pelvic
exenteration-our initial experience in 15 cases. Eur J Gynaecol
Oncol. 36:142–145. 2015.PubMed/NCBI
|
|
22
|
Bacalbasa N, Balescu I, Vilcu M, Neacsu A,
Dima S, Croitoru A and Brezean I: Pelvic exenteration for locally
advanced and relapsed pelvic malignancies-an analysis of 100 cases.
In Vivo. 33:2205–2210. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lewandowska A, Szubert S, Koper K, Koper
A, Cwynar G and Wicherek L: Analysis of long-term outcomes in 44
patients following pelvic exenteration due to cervical cancer.
World J Surg Onc. 18(234)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Goldberg JM, Piver MS, Hempling RE, Aiduk
C, Blumenson L and Recio FO: Improvements in pelvic exenteration:
Factors responsible for reducing morbidity and mortality. Ann Surg
Oncol. 5:399–406. 1998.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kramer C, Peschel RE, Goldberg N, Kohorn
EI, Chambers JT, Chambers SK and Schwartzet PE: Radiation treatment
of FIGO stage IVA carcinoma of the cervix. Gynecol Oncol.
32:323–326. 1989.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Moore KN, Gold MA, McMeekin DS and Zorn
KK: Vesicovaginal fistula formation in patients with stage IVA
cervical carcinoma. Gynecol Oncol. 106:498–501. 2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Forner DM and Lampe B: Exenteration as a
primary treatment for locally advanced cervical cancer: Long-term
results and prognostic factors. Am J Obstet Gynecol. 205:148.e1–e6.
2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ahmadi N, Tan KK, Solomon MJ, Al-Mozany N
and Carter J: Pelvic exenteration for primary and recurrent
gynecologic malignancies is safe and achieves acceptable long-term
outcomes. J Gynecol Surg. 30:255–259. 2014.
|
|
29
|
Höckel M, Horn LC and Einenkel J:
(Laterally) extended endopelvic resection: Surgical treatment of
locally advanced and recurrent cancer of the uterine cervix and
vagina based on ontogenetic anatomy. Gynecol Oncol. 127:297–302.
2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Li L, Ma SQ, Tan XJ, Zhong S and Wu M:
Pelvic exenteration for recurrent and persistent cervical cancer.
Chin Med J (Engl). 131:1541–1548. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Căpîlna ME, Szabo B, Rusu SC, Becsi J,
Moldovan B, Neagoe RM and Muhlfay G: Anatomical variations of the
obturator veins and their surgical implications. Eur J Gynaecol
Oncol. 38:263–265. 2017.PubMed/NCBI
|
|
32
|
Zoucas E, Frederiksen S, Lydrup ML,
Månsson W, Gustafson P and Alberius P: Pelvic exenteration for
advanced and recurrent malignancy. World J Surg. 34:2177–2184.
2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Andikyan V, Khoury-Collado F, Gerst SR,
Talukdar S, Bochner BH, Sandhu JS, Abu-Rustum N, Sonoda Y, Barakat
RR and Chi DS: Anterior pelvic exenteration with total vaginectomy
for recurrent or persistent genitourinary malignancies: Review of
surgical technique, complications, and outcome. Gynecol Oncol.
126:346–350. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Chiva L, Zanagnolo V, Querleu D,
Martin-Calvo N, Arévalo-Serrano J, Căpîlna ME, Fagotti A,
Kucukmetin A, Mom C, Chakalova G, et al: SUCCOR study: An
international European cohort observational study comparing
minimally invasive surgery versus open abdominal radical
hysterectomy in patients with stage IB1 cervical cancer. Int J
Gynecol Cancer. 30:1269–1277. 2020.PubMed/NCBI View Article : Google Scholar
|
